A new study published in the Journal of Addiction Medicine conducted by a team of Stony Brook University researchers used the PROMOTE Prenatal Screener – a unique screening tool for use during pregnancy – to pinpoint vulnerabilities for substance use.
University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.
Health System to serve as a lead core enrollment site for diverse, national health database
UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.
A new study found that higher levels of stereotypical male gender expression were associated with a decrease in reported diagnoses and treatment for cardiovascular disease risk factors.
A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.
Researchers from WashU Medicine and Northwestern University developed an implantable device that can detect an overdose and rapidly deliver naloxone.
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
A study that used a specialized type of magnetic resonance imaging (MRI), named neuromelanin-sensitive MRI, showed that this type of MRI signal was increased in regions of the midbrain in young adults ages 20 to 24 who had an extensive alcohol and drug use history. The findings are published early online in the American Journal of Psychiatry.
Injuries and substance abuse are leading causes of adolescent deaths. Screening adolescents for substance use can reduce the risk of future drug and alcohol use and reinjury. But how are clinicians deciding who to screen?
The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
Rutgers Health research finds the medications of grandparents and pets, as well as discarded items, pose unexpected hazards for young children.
Behavioral health professionals at Rutgers will work with the state to increase and improve the delivery of mental health and substance use services to the underserved communities of Newark and Elizabeth under a $4.5 million federal grant.
One in 5 older adults used cannabis products that include THC in the last year. Among them, 20% said they drove within 2 hours of using cannabis, and a similar percentage said they experience at least one potential signs of addiction.
Since the COVID-19 pandemic, rates of chronic absenteeism have nearly doubled across the nation for students in kindergarten through grade 12.This increase was tied to the mode of instruction during the early years of the pandemic.
A national initiative led by the National Institutes for Mental Health is now underway to find figurative “rulers” that can accurately measure and compare the quality of the various mental health treatments available.
Certain concepts have a demonstrated basis for aiding recovery from dangerous alcohol or substance use, according to an analysis of scientific literature since 1990. Self-efficacy (a belief in one's ability to achieve a goal), social support, and managing cravings are among the treatment elements best supported by evidence. Effective treatment for alcohol use disorder (AUD) and other substance use disorders (SUDs) depends on understanding how human behaviors change and incorporating that knowledge into clinical practice. An ongoing research effort continues to investigate varying treatment approaches and how they relate to recovery outcomes, but those findings have not been well synthesized into a useful format. For the new review published in Alcohol: Clinical & Experimental Research, researchers from around the USA reviewed published studies, identified the treatment elements best supported by data, and evaluated their potential as key factors in behavior change. The researchers drew
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as the inaugural Director of the School’s Kahlert Institute for Addiction Medicine
FAU joins the National Academy of Medicine’s Action Collaborative on Combating Opioid Crises. This pilot project, involving more 80 organizations, aims to enhance coordination and address addiction challenges through collaboration among public, private and nonprofit sectors.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
